Breast Cancer Trial, Recruiting (NCT06807502)

Breast Cancer Trial, Recruiting NCT06807502 Sponsor: ScreenCell Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06807502 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be a woman aged 18 or older
If you have metastatic breast cancer: You have breast cancer that has spread to other parts of the body, either from the start or after previous treatment, and you are changing to a new treatment at the time of joining the trial
If you have non-metastatic invasive breast cancer: You have breast cancer that has not spread to other parts of the body, and you have not yet received any treatment for it
If you are a healthy volunteer: You have no cancer at the time of joining, you have had a satisfactory mammogram within the last two years, and you have no history of cancer in the past

Who may not be able to join:

Men are not eligible for this trial
Anyone under the age of 18
Anyone who does not wish to participate or who withdraws their consent
Women who are pregnant or breastfeeding
Anyone who is found to have a new cancer (other than breast cancer, for patients) during the course of the trial
Healthy volunteers who have a history of cancer
Healthy volunteers in whom circulating tumour cells are detected during initial screening tests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0033669645318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06807502

Sponsor: ScreenCell

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 0033669645318

More information: https://clinicaltrials.gov/study/NCT06807502

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be a woman aged 18 or older
If you have metastatic breast cancer: You have breast cancer that has spread to other parts of the body, either from the start or after previous treatment, and you are changing to a new treatment at the time of joining the trial
If you have non-metastatic invasive breast cancer: You have breast cancer that has not spread to other parts of the body, and you have not yet received any treatment for it
If you are a healthy volunteer: You have no cancer at the time of joining, you have had a satisfactory mammogram within the last two years, and you have no history of cancer in the past

Who may not be able to join:

Men are not eligible for this trial
Anyone under the age of 18
Anyone who does not wish to participate or who withdraws their consent
Women who are pregnant or breastfeeding
Anyone who is found to have a new cancer (other than breast cancer, for patients) during the course of the trial
Healthy volunteers who have a history of cancer
Healthy volunteers in whom circulating tumour cells are detected during initial screening tests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ScreenCell

Registry

ClinicalTrials.gov

Start date

24 February 2025

Est. completion

30 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evolution of the kinetics of CTC during treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov